The collaboration means the PPD clinical research business and its customers can reduce greenhouse gas emissions from global clinical research air shipping logistics by up to 80%.
Using SAF is one of Thermo Fisher’s ways to cut its carbon footprint with other initiatives including using renewable energy for powering clinical trial sites and labs.
Travis Cobb, Executive Vice President Global Network Operations & Aviation at DHL Express, says, “Both DHL and the PPD clinical research business share a strong commitment to carbon footprint reduction. We are pleased they can now offer their customers an emission-reduced global shipping solution. Efficient logistics isn't just about moving goods - it's about moving toward a sustainable future with every delivery we make.”
Thermo Fisher is committed to net zero emissions by 2050 and its near-term climate targets have been validated by the Science Based Targets initiative (SBTi).
Leon Wyszkowski, President, Analytical Services, Clinical Research at Thermo Fisher Scientific says clinical research needs quick deliveries, often overnight, so most packages need to be shipped by air.
He says, “Given this constraint on changing transportation modes, our greatest short-term opportunity to reduce shipping emissions lies in using more sustainable fuels for air transport. By using SAF, we can immediately reduce our emissions from air shipments with DHL Express by up to 80%.”